Rick Maffei

0.5 AMA PRA Category 1 Credit(s)^TM
0.5 IPCE Credit
0.5 AANP Contact Hour(s) which includes 0.25 pharmacology hours

0.25 AMA PRA Category 1 Credit(s)^TM
0.25 IPCE Credit
0.25 AANP Contact Hour(s) which includes 0.25 pharmacology hours

The Obesity Paradox in Renal Cell Carcinoma Obesity has been associated with both an increased risk for RCC and a better prognosis from RCC. Why do patients who are obese tend to have more favorable clinical outcomes? Find out now.  

Can Molecular Profiling Help Identify Patients at Risk for MPN-SVT? Investigators recruited 80 patients with a diagnosis of Budd-Chiari syndrome or portal vein thrombosis and MPN who had available next-generation sequencing data for this study. Learn more.  

Molecular Response in CML Maintained With Intermittent TKI Regimen Could this type of intermittent treatment be an option for patients receiving TKIs for CML who do not achieve a stable deep molecular response and are not eligible for treatment discontinuation? Find out now.  

1.0 AMA PRA Category 1 Credit(s)^TM
1.0 IPCE Credit
1.0 AANP Contact Hour(s) which includes 0.75 pharmacology hours

1.0 AMA PRA Category 1 Credit(s)^TM
1.0 AANP Contact Hour(s) which includes 1.0 pharmacology hours

Sponsored Content See Data for a New Resectable NSCLC Treatment New treatment option for patients with resectable non-small cell lung cancer. Learn more.  

1.0 AMA PRA Category 1 Credit(s)^TM
1.0 AANP Contact Hour(s) which includes 0.50 pharmacology hours